GZMB and tuberculosis: Our observation that granzyme B gene upregulation and protein secretion occur in PBMC from patients at the time of TB-IRIS symptom onset, and that secretion is reduced in PBMC from patients treated for TB-IRIS by prednisone, which improves symptoms and reduces hospitalization, supports a role for cytotoxic mediators in the immunopathology of TB-IRIS.